You might also like

Availability alert

More about Analysis File of Drug-Induced Lung Injury

• Book details
• Synopsis
• Trending among others

You get 309 loyalty points

Book synopsis

This book describes the pathologic conditions of drug-induced lung injuries, monitoring strategies, and guides on how to interpret the evidence. It also dives into particular drugs that caused the disorder, such as EGFR inhibitors, anti-EGFR antibodies, mTOR inhibitors, proteasome inhibitors, immune checkpoint inhibitors, neoangiogenesis inhibitors, and other molecular targeted drugs. It outlines the analysis and interpretation of the post-marketing survey on surveillance of each drug for inducing pulmonary lesions presenting diffuse haziness. The data and analysis from this survey are valuable since a guideline is yet to be established due to limited clinical evidence and cases. As new drugs are developed, establishing treatment and event management is crucial. Thus, Drug-induced Pulmonary Disorder in Medical Oncology - Expert Opinion to Decipher Big Data summarizes the accumulated information to provide a foundation for further research advancement. The book offers a refreshing alternative to current approaches to medical oncology and respiratory diseases professionals and will also attract medical affairs members in global pharmaceutical companies. 

Book details

Book category Knihy po anglicky Medicine Clinical & internal medicine Respiratory medicine

• Full title: Analysis File of Drug-Induced Lung Injury
• Subtitle: Expert Opinion for Analysis of Big Data
• Author: Akihiko Gemma
• Language: English
• Binding: Hardback
• Number of pages: 110
• EAN: 9789819734450
• ID: 45786893
• Publisher: Springer, Berlin
• Dimensions: 235 × 155 mm
• Date of publishing: 29. September 2024

---

---

---